Mvasi (bevacizumab)

pCPA File Number: 21101
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Colorectal Cancer / Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
PC0158-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: